280 related articles for article (PubMed ID: 32921328)
21. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
Front Immunol; 2020; 11():607734. PubMed ID: 33569053
[No Abstract] [Full Text] [Related]
22. Probiotics potentials in mitigating coronavirus disease (COVID-19) pandemic.
Reuben RC; Makut MD; Adogo LY
Pan Afr Med J; 2021; 38():186. PubMed ID: 33995792
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
24. Effect of probiotics as an immune modulator for the management of COVID-19.
Ray M; Manjunath A; Halami PM
Arch Microbiol; 2023 Apr; 205(5):182. PubMed ID: 37031431
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.
Zhang L; Xu Z; Mak JWY; Chow KM; Lui G; Li TCM; Wong CK; Chan PKS; Ching JYL; Fujiwara Y; Chan FKL; Ng SC
J Gastroenterol Hepatol; 2022 May; 37(5):823-831. PubMed ID: 35170078
[TBL] [Abstract][Full Text] [Related]
26. The integumentary system and its microbiota between health and disease.
Inchingolo AD; Cazzolla AP; Di Cosola M; Greco Lucchina A; Santacroce L; Charitos IA; Topi S; Malcangi G; Hazballa D; Scarano A; Lorusso F; Inchingolo AM; Inchingolo F; Dipalma G
J Biol Regul Homeost Agents; 2021; 35(2 Suppl. 1):303-321. PubMed ID: 34281327
[TBL] [Abstract][Full Text] [Related]
27. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Microbiota-A Promising Target for Antiviral Therapy?
Yang M; Yang Y; He Q; Zhu P; Liu M; Xu J; Zhao M
Front Immunol; 2021; 12():676232. PubMed ID: 34054866
[TBL] [Abstract][Full Text] [Related]
29. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
[TBL] [Abstract][Full Text] [Related]
30. Probiotics and COVID-19: is there any link?
Akour A
Lett Appl Microbiol; 2020 Sep; 71(3):229-234. PubMed ID: 32495940
[TBL] [Abstract][Full Text] [Related]
31. Probiotic supplementation: A prospective approach in the treatment of COVID-19.
Nayebi A; Navashenaq JG; Soleimani D; Nachvak SM
Nutr Health; 2022 Jun; 28(2):163-175. PubMed ID: 34747257
[No Abstract] [Full Text] [Related]
32. Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients.
Ahsan K; Anwar MA; Munawar N
World J Gastroenterol; 2023 Mar; 29(11):1708-1720. PubMed ID: 37077515
[TBL] [Abstract][Full Text] [Related]
33. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
Hu J; Zhang L; Lin W; Tang W; Chan FKL; Ng SC
Trends Food Sci Technol; 2021 Feb; 108():187-196. PubMed ID: 33519087
[TBL] [Abstract][Full Text] [Related]
34. Impact of COVID-19 on the Intestinal Microbiome.
Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
[TBL] [Abstract][Full Text] [Related]
35. Ameliorating effects of probiotics on alterations in iron homeostasis and inflammation in COVID-19.
El-Sayed EM; Ibrahim KS
Mol Biol Rep; 2022 Jun; 49(6):5153-5163. PubMed ID: 35169998
[TBL] [Abstract][Full Text] [Related]
36. The role of probiotics in COVID-19 treatment: Gut microbiota can help physicians in the outbreak.
Şahin M
Turk J Gastroenterol; 2020 Oct; 31(10):724-725. PubMed ID: 33169711
[No Abstract] [Full Text] [Related]
37. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19.
S A; K G; A AM
J Biomol Struct Dyn; 2022; 40(24):14262-14278. PubMed ID: 34699326
[TBL] [Abstract][Full Text] [Related]
38. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
39. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
40. The impact of probiotics on interactions within the microbiota-gut-lung triad in COVID-19.
Mulak A
Int J Food Sci Nutr; 2021 Jun; 72(4):577-578. PubMed ID: 33390092
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
